Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04488705
Status:
COMPLETED
Last Update Posted:
2021-05-21
First Post:
2020-07-23
Brief Title:
A First in Human Study to Evaluate the Safety Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects
Sponsor:
Enterprise Therapeutics Ltd
Organization:
Enterprise Therapeutics Ltd
Organization Data
Organization:
Enterprise Therapeutics Ltd
Class:
INDUSTRY
Study ID:
ET-TMEM-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Enterprise Therapeutics Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None